Funding for trials of the Russian melanoma vaccine has been stopped
Sergey Kiselyov, Professor, Doctor of Sciences, Head of the Laboratory of Genetic Foundations of Cellular Technologies at the Institute of General Genetics of the Russian Academy of Sciences, told Medical News about the process of developing a therapeutic vaccine against melanoma (skin cancer) and the results of its testing.
01.02.2013